Amneal Pharmaceuticals, Inc. (AMRX)
Amneal Pharmaceuticals, Inc. (AMRX)
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 197,656 | 282,029 | 201,249 | 71,544 |
| Restricted cash | 4,174 | 28,842 | 34,727 | 9,642 |
| Receivables-Nonrelated Party | 850,860 | 895,143 | 885,199 | 807,637 |
| Inventories | 641,618 | 606,302 | 614,500 | 608,973 |
| Prepaid expenses and other current assets | 103,091 | 98,395 | 101,511 | 85,304 |
| Receivables-Related Party | 508 | 470 | 1,292 | 1,592 |
| Total current assets | 1,797,907 | 1,911,181 | 1,838,478 | 1,584,692 |
| Property, plant and equipment, net | 444,607 | 442,950 | 434,991 | 440,327 |
| Goodwill | 593,800 | 595,470 | 595,945 | 597,406 |
| Net | NaN | 555,398 | 579,838 | NaN |
| In-process research and development | NaN | 8,100 | 8,100 | NaN |
| Intangible assets, net | 534,869 | 563,498 | 587,938 | 649,547 |
| Operating lease right-of-use assets-Nonrelated Party | 46,748 | 38,832 | 31,769 | 33,241 |
| Operating lease right-of-use assets-Related Party | 14,473 | 15,216 | 16,875 | 17,658 |
| Financing lease right-of-use assets-Nonrelated Party | 52,934 | 53,328 | 54,420 | 55,068 |
| Other assets | 54,880 | 57,805 | 39,458 | 44,849 |
| Total assets | 3,540,218 | 3,678,280 | 3,599,874 | 3,422,788 |
| Accounts payable and accrued expenses-Nonrelated Party | 662,975 | 761,316 | 731,825 | 666,817 |
| Current portion of liabilities for legal matters | 10,550 | 43,256 | 40,598 | 41,515 |
| Revolving credit facility | NaN | 0 | 0 | 290,000 |
| Current portion of long-term debt, net | 6,200 | 6,761 | 7,202 | 31,175 |
| Current portion of operating lease liabilities-Nonrelated Party | 8,922 | 8,668 | 7,985 | 8,223 |
| Current portion of operating lease liabilities-Related Party | 2,830 | 2,705 | 2,826 | 2,701 |
| Current portion of financing lease liabilities-Nonrelated Party | 3,533 | 3,442 | 3,458 | 3,307 |
| Accounts payable and accrued expenses-Related Party | 33,039 | 55,485 | 68,212 | 63,396 |
| Total current liabilities | 728,049 | 881,633 | 862,106 | 1,107,134 |
| Long-term debt, net | 2,565,558 | 2,565,115 | 2,566,500 | 2,146,403 |
| Operating lease liabilities-Nonrelated Party | 41,101 | 33,233 | 26,405 | 27,623 |
| Operating lease liabilities-Related Party | 13,467 | 14,195 | 15,676 | 16,441 |
| Financing lease liabilities-Nonrelated Party | 54,876 | 54,927 | 55,672 | 56,020 |
| Related party payables - long term-Related Party | 456 | 19,132 | 8,587 | 15,607 |
| Liabilities for legal matters - long term | 70,021 | 71,819 | 74,477 | 74,477 |
| Related party payables - long term-Nonrelated Party | 26,747 | 32,263 | 32,626 | 25,814 |
| Total long-term liabilities | 2,772,226 | 2,790,684 | 2,779,943 | 2,362,385 |
| Redeemable non-controlling interests | 85,912 | 77,292 | 67,780 | 65,802 |
| Common stock-Common Class A | 3,190 | 3,146 | 3,143 | 3,140 |
| Common stock-Common Class B | 0 | 0 | 0 | 0 |
| Additional paid-in capital | 536,299 | 571,794 | 563,363 | 554,623 |
| Stockholders accumulated deficit | -472,749 | -535,005 | -570,081 | -572,450 |
| Accumulated other comprehensive loss | -112,151 | -110,729 | -105,883 | -97,431 |
| Total amneal pharmaceuticals, inc. stockholders deficiency | -45,411 | -70,794 | -109,458 | -112,118 |
| Non-controlling interests | -558 | -535 | -497 | -415 |
| Total stockholders deficiency | -45,969 | -71,329 | -109,955 | -112,533 |
| Total liabilities and stockholders deficiency | 3,540,218 | 3,678,280 | 3,599,874 | 3,422,788 |